Skip directly to Accessibility Notice

CNXT
VanEck ChiNext ETF

Fund Description

VanEck ChiNext ETF (CNXT®) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the ChiNext Index (SZ988107), which tracks the performance of the 100 largest and most liquid stocks listed and trading on the ChiNext Market of the Shenzhen Stock Exchange. The ChiNext Index is comprised of China A-shares (“A-shares”).

 
 

  • Fund Ticker

    CNXT
  • Exchange

    NYSE Arca
  • Inception Date

    07/23/2014
  • ETF Structure

    Physical
  • Administrator

    Van Eck Associates
  • Index Ticker

    SZ988107
  • Index Rebalancing

    Semi-Annually

  as of 03/27/23

  • 30-Day SEC Yield1

    -0.14%
  • Total Net Assets

    $28.8M
  • Number of Holdings

    99
  • Options

    Available
  • Gross Expense Ratio2

    0.89%
  • Net Expense Ratio/TER2

    0.65%
  • Distribution Frequency

    Annual
  • Next Distribution Date

    12/15/2023

Fund Highlights

  • Innovative and entrepreneurial Chinese companies
    Tracks the largest 100 names on the ChiNext Market

  • Strategic Sector Focus
    High exposure to sectors such as information technology, new materials and healthcare, with low exposure to state owned enterprises

  • Historically High ROE May Support Growth Potential
    The underlying index has historically had a higher average Return on Equity (ROE) compared to China A-share small-cap benchmarks.

Trading Information

  • Fund Ticker

    CNXT
  • Index Total Return Ticker

    SZ988107
  • NAV

    CNXTNV
  • Intraday NAV (IIV)4

    CNXTIV
  • Shares Outstanding

    900,000
  • Estimated Cash

    CNXTEU
  • Total Cash

    CNXTTCA
  • CUSIP

    92189F627
  • ISIN

    US92189F6271
Source: Bloomberg

Fees and Expenses2

  • Management Fee

    0.50%
  • Other Expenses

    0.39%
  • Gross Expense Ratio

    0.89%
  • Fee Waivers and
    Expense Reimbursement

    -0.24%
  • Net Expense Ratio/TER2

    0.65%

Expenses for CNXT are capped contractually at 0.65% until May 1, 2023. Cap excludes acquired fund fees and expenses, trading expenses, taxes and extraordinary expenses.

Morningstar™ Ratings3 as of 02/28/2023

Category Overall 3 Year 5 Year
China Region

Morningstar Ratings: When applicable, ratings shown when the ETF is rated three stars or more for any given period. For each fund with at least a three-year history, Morningstar calculates a Morningstar Rating based on a Morningstar Risk-Adjusted Return measure that accounts for variation in a fund's monthly performance (including the effects of sales charges, loads, and redemption fees), placing more emphasis on downward variations and rewarding consistent performance. The top 10% of funds in each category receive 5 stars, the next 22.5% receive 4 stars, the next 35% receive 3 stars, the next 22.5% receive 2 stars and the bottom 10% receive 1 star. (Each share class is counted as a fraction of one fund within this scale and rated separately, which may cause slight variations in the distribution percentages.) The Overall Morningstar Rating for a fund is derived from a weighted average of the performance figures associated with its three-, five- and ten-year (if applicable) Morningstar Rating metrics.

© Morningstar, Inc. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.

Investment Professionals

  • Portfolio Manager and Head of Equity ETFs
  • Oversees the Equity ETF Investment Management Team including development and management of index replication and optimization strategies
  • Joined VanEck in 2005
  • CFA charterholder; member of the CFA Society New York
  • BA, Mathematics and Economics, New York University
  • Analyst for Equity ETFs
  • Joined VanEck in 2018
  • Prior to joining VanEck, ETF Basket Operations Analyst at JPMorgan
  • BS, Finance, Providence College
  • Analyst for Equity ETFs
  • Joined VanEck in 2019
  • Prior to VanEck, Intermediate Representative, Exchange Traded Funds at BNY Mellon.
  • BS, Accounting, Hunter College

Prices as of 03/27/23

NAV/
Market
Price
Volume
30-Day Avg./
Last Trading Day
Daily Change
NAV/
Last Price
YTD Change NAV/
Last Price
Premium/
Discount
30-Day
Median
Bid Ask
Spread
NAV
Chart
CNXT $31.97
$32.04
10,870
3,514
$0.19 / +0.58%
$0.17 / +0.55%
+2.26%
+2.64%
$0.07
0.22%
0.22%

Premium/Discount History as of 03/27/23

Calendar Year 2021 1Q 2022 2Q 2022 3Q 2022 4Q 2022 Premium/Discount Charts NAV & Prem/Discount History
CNXT Days closed at a premium 88 4 15 37 25
Days closed at NAV 5 1 0 2 2
Days closed at a discount 159 57 47 25 36

Performance History: Average Annual Total Returns* (%)

  1 MO 3 MO YTD 1 YR 3 YR 5 YR 10 YR LIFE
07/23/14
CNXT (NAV) -9.30 3.83 2.88 -24.62 3.06 0.27 -- 4.28
CNXT (Share Price) -9.29 3.51 2.95 -23.76 3.79 0.25 -- 4.27
SZ988107 (Index) -8.57 6.50 3.66 -23.12 4.64 1.97 6.40 6.66
Performance Differential (NAV - Index) -0.73 -2.67 -0.78 -1.50 -1.58 -1.70 -- -2.38
  1 MO 3 MO YTD 1 YR 3 YR 5 YR 10 YR LIFE
07/23/14
CNXT (NAV) 0.92 5.66 -35.49 -35.49 4.66 -0.27 -- 4.01
CNXT (Share Price) 0.54 5.37 -35.59 -35.59 4.69 -0.19 -- 3.99
SZ988107 (Index) 2.75 4.39 -35.09 -35.09 6.74 1.73 7.09 6.34
Performance Differential (NAV - Index) -1.83 1.27 -0.40 -0.40 -2.08 -2.00 -- -2.33

Top 10 Holdings (%) as of 02/28/23

Daily Holdings
Total Holdings: 99
Holding Name
Ticker
Shares
Market Value
(US$)
% of Net
Assets
Contemporary Amperex Technology Co Ltd
300750 CH
58,400
3,382,703 16.18
East Money Information Co Ltd
300059 CH
475,620
1,427,686 6.83
Shenzhen Mindray Bio-Medical Electronic
300760 CH
21,200
956,198 4.57
Shenzhen Inovance Technology Co Ltd
300124 CH
84,185
886,632 4.24
Sungrow Power Supply Co Ltd
300274 CH
45,800
786,136 3.76
Wens Foodstuffs Group Co Ltd
300498 CH
243,860
693,442 3.32
Aier Eye Hospital Group Co Ltd
300015 CH
137,362
616,522 2.95
Eve Energy Co Ltd
300014 CH
57,096
595,867 2.85
Chongqing Zhifei Biological Products Co
300122 CH
34,769
447,948 2.14
Walvax Biotechnology Co Ltd
300142 CH
74,200
407,744 1.95
Top 10 Total (%) 48.78
← Scroll for more information →
These are not recommendations to buy or to sell any security. Securities and holdings may vary.

Country Weightings (%)
as of 02/28/23

Country % of Net Assets
China 98.90
United States 0.98
Other/Cash 0.13

Sector Weightings (%)
as of 02/28/23

Sector % of Net Assets
Industrials 36.57
Health Care 24.28
Information Technology 15.48
Materials 7.79
Financials 7.58
Consumer Staples 5.40
Communication Services 1.43
Consumer Discretionary 1.35
Other/Cash 0.13

View More Funds

loading...